ATGC Inc. (ATGC) is “A Translational Genomics Company”. The company is dedicated to the development of novel transgenic rabbits as discovery platforms and bioreactors for therapeutic biologics such as monoclonal antibodies. 

Our mission is to discover the best-in-class therapeutics through the novel platforms. ATGC also strives to serve the biomedical community with products and services using our unique platforms. Contact us to learn more.